NCT07465523 A Novel Approach in the Evaluation of Breast Masses With Doppler US
| NCT ID | NCT07465523 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ahmet Yesildag |
| Condition | Breast Neoplasm Female |
| Study Type | OBSERVATIONAL |
| Enrollment | 90 participants |
| Start Date | 2026-03-04 |
| Primary Completion | 2026-05-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 90 participants in total. It began in 2026-03-04 with a primary completion date of 2026-05-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In cases with breast masses, Doppler resistive index values will be calculated for the mass and surrounding healthy tissue and the opposite healthy breast tissue, and their effect on distinguishing between benign and malignant masses will be evaluated.
Eligibility Criteria
Inclusion Criteria: * Those with solid breast masses * Female patients * Those with pathology results Exclusion Criteria: * Hypovascular masses * Cystic breast masses * Cases with mastitis
Contact & Investigator
Ahmet Yeşildağ, Prof.Dr.
STUDY DIRECTOR
Karamanoğlu Mehmetbey Universty
Frequently Asked Questions
Who can join the NCT07465523 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Neoplasm Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07465523 currently recruiting?
Yes, NCT07465523 is actively recruiting participants. Contact the research team at ahmetysd@hotmail.com for enrollment information.
Where is the NCT07465523 trial being conducted?
This trial is being conducted at Karaman, Turkey (Türkiye).
Who is sponsoring the NCT07465523 clinical trial?
NCT07465523 is sponsored by Ahmet Yesildag. The principal investigator is Ahmet Yeşildağ, Prof.Dr. at Karamanoğlu Mehmetbey Universty. The trial plans to enroll 90 participants.